News

HeartLight® X3 System has significantly shorter procedure times for atrial fibrillation ablation CardioFocus, Inc., a medical device company dedicated to advancing ablation treatment for atrial fibrillation (AFib), announced that results...

A transatlantic study collaboration between researchers from Canada and Germany has demonstrated that a wearable heart monitor device can significantly improve the detection of atrial fibrillation, a major risk factor for stroke. The study...

A smart-alert study to guide anticoagulant treatment for patients with atrial fibrillation Sky Labs, a healthcare startup, announced that CART-I, its ring-type heart-monitoring device, had been provided for Timothy Betts, professor of...

RhythMedix, a leader in remote cardiac monitoring, announced the release of its next-generation RhythmStar® wearable device with built-in 4G cellular connectivity. The novel cardiac telemetry monitor is discreetly worn for extended remote...

EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist Marina Izzo as Chief Executive Officer (CEO). Mrs. Izzo will set the vision for EBAMed’s technology and lead...

Researchers have used the zebrafish (Danio rerio) to identify the role of a gene involved in cardiac rhythm, which could help explain the fundamentals of what it takes to make a human heartbeat Researchers have used the zebrafish (Danio...

Strategic collaboration leverages AliveCor's diagnostics and AI capabilities AliveCor, the leader in AI-based personal ECG technology and provider of enterprise cardiology solutions, announced a new collaboration with AstraZeneca, a global...

Physicians with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center are among the first in the world to participate in a clinical trial to evaluate a new esophageal protection device designed to make ablation...

MedLumics, a privately held medical device company developing AblaView®, the first optically-guided real-time ablation catheter system for the treatment of Atrial Fibrillation (AF), announced that it has closed an upsized EUR 18 million (USD...

A physician with the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center is among the first in the world to participate in a clinical trial to evaluate the safety and efficacy of a new cardiac-specific catheter used during...